Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients

HighlightsInnate immune activation during Covid-19 infection is associated with pernicious clinical outcome.BackgroundCoronavirus disease 2019 (Covid-19) is a worldwide threat that has already caused more than 3 000 000 deaths. It is characterized by different patterns of disease evolution depending...

Full description

Bibliographic Details
Main Authors: Manon Chauvin, Martin Larsen, Bibiana Quirant, Paul Quentric, Karim Dorgham, Luca Royer, Hélène Vallet, Amelie Guihot, Béhazine Combadière, Christophe Combadière, Jaume Barallat, Julien Mayaux, Charles-Edouard Luyt, Alexis Mathian, Zahir Amoura, Jacques Boddaert, Fernando Armestar, Guy Gorochov, Eva Martinez-Caceres, Delphine Sauce
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.709893/full
_version_ 1819139837196763136
author Manon Chauvin
Martin Larsen
Bibiana Quirant
Bibiana Quirant
Paul Quentric
Karim Dorgham
Luca Royer
Hélène Vallet
Hélène Vallet
Amelie Guihot
Amelie Guihot
Béhazine Combadière
Christophe Combadière
Jaume Barallat
Julien Mayaux
Charles-Edouard Luyt
Alexis Mathian
Alexis Mathian
Zahir Amoura
Zahir Amoura
Jacques Boddaert
Jacques Boddaert
Fernando Armestar
Fernando Armestar
Guy Gorochov
Guy Gorochov
Eva Martinez-Caceres
Eva Martinez-Caceres
Delphine Sauce
author_facet Manon Chauvin
Martin Larsen
Bibiana Quirant
Bibiana Quirant
Paul Quentric
Karim Dorgham
Luca Royer
Hélène Vallet
Hélène Vallet
Amelie Guihot
Amelie Guihot
Béhazine Combadière
Christophe Combadière
Jaume Barallat
Julien Mayaux
Charles-Edouard Luyt
Alexis Mathian
Alexis Mathian
Zahir Amoura
Zahir Amoura
Jacques Boddaert
Jacques Boddaert
Fernando Armestar
Fernando Armestar
Guy Gorochov
Guy Gorochov
Eva Martinez-Caceres
Eva Martinez-Caceres
Delphine Sauce
author_sort Manon Chauvin
collection DOAJ
description HighlightsInnate immune activation during Covid-19 infection is associated with pernicious clinical outcome.BackgroundCoronavirus disease 2019 (Covid-19) is a worldwide threat that has already caused more than 3 000 000 deaths. It is characterized by different patterns of disease evolution depending on host factors among which old-age and pre-existing comorbidities play a detrimental role. Previous coronavirus epidemics, notably SARS-CoV, were associated with increased serum neopterin levels, which can be interpreted as a sign of acute innate immunity in response to viral infection. Here we hypothesize that neopterin may serve as a biomarker of SARS-CoV-2 viral infection and Covid-19 disease severity.MethodsWe measured neopterin blood levels by ELISA. Seric concentration was quantified from 256 healthy donors and 374 Covid-19 patients at hospital admission. Enrolled Covid-19 patients were all symptomatic and displayed a large spectrum of comorbidities. Patients were followed until disease resolution or death.ResultsSevere and critically ill SARS-CoV-2 infected patients were characterized by a profound exacerbation of immune activation characterized by elevated neopterin blood levels. Systemic neopterin levels above 19nM stratified healthy individuals from Covid-19 patients with 87% specificity and 100% sensitivity. Moreover, systemic neopterin levels above 53nM differentiated non-survivors from survivors with 64% specificity and 100% sensitivity.ConclusionWe propose that neopterin concentration measured at arrival to hospital is a hallmark of severe Covid-19 and identifies a high-risk population of pernicious clinical outcome with a need for special medical care.
first_indexed 2024-12-22T11:29:00Z
format Article
id doaj.art-0d56510dfa394fddb3e0d10f4d9e8ef4
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-22T11:29:00Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-0d56510dfa394fddb3e0d10f4d9e8ef42022-12-21T18:27:39ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-08-011110.3389/fcimb.2021.709893709893Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected PatientsManon Chauvin0Martin Larsen1Bibiana Quirant2Bibiana Quirant3Paul Quentric4Karim Dorgham5Luca Royer6Hélène Vallet7Hélène Vallet8Amelie Guihot9Amelie Guihot10Béhazine Combadière11Christophe Combadière12Jaume Barallat13Julien Mayaux14Charles-Edouard Luyt15Alexis Mathian16Alexis Mathian17Zahir Amoura18Zahir Amoura19Jacques Boddaert20Jacques Boddaert21Fernando Armestar22Fernando Armestar23Guy Gorochov24Guy Gorochov25Eva Martinez-Caceres26Eva Martinez-Caceres27Delphine Sauce28Sorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceDivision of Immunology, Germans Trias i Pujol University Hospital and Research Institute, Badalona, SpainDepartment of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), SpainSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceAssistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Unité de Gériatrie Aigue, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceAssistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Département d’Immunologie, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceBiochemistry Department, Germans Trias i Pujol University Hospital, Badalona, SpainAssistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Service de Médecine Intensive–Réanimation et Pneumologie, Paris, FranceService de Médecine Intensive Réanimation, Institut de Cardiologie, Assistance Publique–Hôpitaux de Paris (APHP), Sorbonne-Université, Service de Médecine Intensive–Réanimation et Pneumologie, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceService de Médecine Interne 2, Institut E3M, Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceService de Médecine Interne 2, Institut E3M, Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Paris, FranceSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France0Assistance Publique–Hôpitaux de Paris (APHP), Sorbonne-Université, Hôpital Pitié–Salpêtrière, Département de Gériatrie, Paris, France1Critical Care Department, Germans Trias i Pujol University Hospital, Badalona, Spain2Department of Medicine Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), SpainSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceAssistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Département d’Immunologie, Paris, FranceDivision of Immunology, Germans Trias i Pujol University Hospital and Research Institute, Badalona, SpainDepartment of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), SpainSorbonne Université, Inserm, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, FranceHighlightsInnate immune activation during Covid-19 infection is associated with pernicious clinical outcome.BackgroundCoronavirus disease 2019 (Covid-19) is a worldwide threat that has already caused more than 3 000 000 deaths. It is characterized by different patterns of disease evolution depending on host factors among which old-age and pre-existing comorbidities play a detrimental role. Previous coronavirus epidemics, notably SARS-CoV, were associated with increased serum neopterin levels, which can be interpreted as a sign of acute innate immunity in response to viral infection. Here we hypothesize that neopterin may serve as a biomarker of SARS-CoV-2 viral infection and Covid-19 disease severity.MethodsWe measured neopterin blood levels by ELISA. Seric concentration was quantified from 256 healthy donors and 374 Covid-19 patients at hospital admission. Enrolled Covid-19 patients were all symptomatic and displayed a large spectrum of comorbidities. Patients were followed until disease resolution or death.ResultsSevere and critically ill SARS-CoV-2 infected patients were characterized by a profound exacerbation of immune activation characterized by elevated neopterin blood levels. Systemic neopterin levels above 19nM stratified healthy individuals from Covid-19 patients with 87% specificity and 100% sensitivity. Moreover, systemic neopterin levels above 53nM differentiated non-survivors from survivors with 64% specificity and 100% sensitivity.ConclusionWe propose that neopterin concentration measured at arrival to hospital is a hallmark of severe Covid-19 and identifies a high-risk population of pernicious clinical outcome with a need for special medical care.https://www.frontiersin.org/articles/10.3389/fcimb.2021.709893/fullSARS-CoV-2biomarkerneopterinclinical outcomedeath
spellingShingle Manon Chauvin
Martin Larsen
Bibiana Quirant
Bibiana Quirant
Paul Quentric
Karim Dorgham
Luca Royer
Hélène Vallet
Hélène Vallet
Amelie Guihot
Amelie Guihot
Béhazine Combadière
Christophe Combadière
Jaume Barallat
Julien Mayaux
Charles-Edouard Luyt
Alexis Mathian
Alexis Mathian
Zahir Amoura
Zahir Amoura
Jacques Boddaert
Jacques Boddaert
Fernando Armestar
Fernando Armestar
Guy Gorochov
Guy Gorochov
Eva Martinez-Caceres
Eva Martinez-Caceres
Delphine Sauce
Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
Frontiers in Cellular and Infection Microbiology
SARS-CoV-2
biomarker
neopterin
clinical outcome
death
title Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
title_full Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
title_fullStr Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
title_full_unstemmed Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
title_short Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
title_sort elevated neopterin levels predict fatal outcome in sars cov 2 infected patients
topic SARS-CoV-2
biomarker
neopterin
clinical outcome
death
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.709893/full
work_keys_str_mv AT manonchauvin elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT martinlarsen elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT bibianaquirant elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT bibianaquirant elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT paulquentric elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT karimdorgham elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT lucaroyer elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT helenevallet elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT helenevallet elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT amelieguihot elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT amelieguihot elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT behazinecombadiere elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT christophecombadiere elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT jaumebarallat elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT julienmayaux elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT charlesedouardluyt elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT alexismathian elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT alexismathian elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT zahiramoura elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT zahiramoura elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT jacquesboddaert elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT jacquesboddaert elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT fernandoarmestar elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT fernandoarmestar elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT guygorochov elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT guygorochov elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT evamartinezcaceres elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT evamartinezcaceres elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients
AT delphinesauce elevatedneopterinlevelspredictfataloutcomeinsarscov2infectedpatients